Gifts at Changing The Present

Alcon ends macular degeneration drug program (Reuters)

by (author unknown), Y! Health Eyes & Vision News on Jul 11, 2008

Reuters - Alcon Inc said on Friday that it
has ended development of anecortave acetate as a treatment for
lowering the risk of a sight-threatening eye disease known as
age-related macular degeneration.


Be the first to comment on this article.

Add a comment


Please do not include any advertisements or offensive material.



Help Us Stop Spam
To help us prevent spam, please log in or type the two words you see in the box below. This will also help digitize books, one word at a time.

cancel

Support
Changing The Present

Your tax-deductible contribution makes this site possible.

Sponsorships Inquiries
See us on facebook™
Spread the Word
Tell A Friend

Mailing List

GO